209 related articles for article (PubMed ID: 26407235)
1. A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
Papayannidis C; DeAngelo DJ; Stock W; Huang B; Shaik MN; Cesari R; Zheng X; Reynolds JM; English PA; Ozeck M; Aster JC; Kuo F; Huang D; Lira PD; McLachlan KR; Kern KA; Garcia-Manero G; Martinelli G
Blood Cancer J; 2015 Sep; 5(9):e350. PubMed ID: 26407235
[No Abstract] [Full Text] [Related]
2. Preclinical analysis of the γ-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia.
Samon JB; Castillo-Martin M; Hadler M; Ambesi-Impiobato A; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Jakubczak J; Randolph S; Cordon-Cardo C; Ferrando AA
Mol Cancer Ther; 2012 Jul; 11(7):1565-75. PubMed ID: 22504949
[TBL] [Abstract][Full Text] [Related]
3. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.
Mendes RD; Canté-Barrett K; Pieters R; Meijerink JP
Haematologica; 2016 Sep; 101(9):1010-7. PubMed ID: 27582570
[TBL] [Abstract][Full Text] [Related]
4. The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia.
Gianni F; Belver L; Ferrando A
Cold Spring Harb Perspect Med; 2020 Mar; 10(3):. PubMed ID: 31570389
[TBL] [Abstract][Full Text] [Related]
5. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
[TBL] [Abstract][Full Text] [Related]
6. Response of NOTCH1-Activated Tracheal Adenoid Cystic Carcinoma to the Gamma Secretase Inhibitor Nirogacestat.
Kieran R; de Paula BHR; Hubank M; Barker A; Paterson AL; Gilligan D; Doherty GJ
JCO Precis Oncol; 2021 Nov; 5():1579-1583. PubMed ID: 34994644
[No Abstract] [Full Text] [Related]
7. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
[TBL] [Abstract][Full Text] [Related]
8. Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia.
Bentley VL; Veinotte CJ; Corkery DP; Pinder JB; LeBlanc MA; Bedard K; Weng AP; Berman JN; Dellaire G
Haematologica; 2015 Jan; 100(1):70-6. PubMed ID: 25281505
[TBL] [Abstract][Full Text] [Related]
9. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic mechanisms underlie resistance to NOTCH inhibition in T-ALL.
Cancer Discov; 2014 May; 4(5):OF11. PubMed ID: 24795015
[TBL] [Abstract][Full Text] [Related]
11. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
12. Preclinical testing of CT1113, a novel USP28 inhibitor, for the treatment of T-cell acute lymphoblastic leukaemia.
Xu J; Peng J; Sun S; Wang D; Yuan W; Yang X; Shi T; Wang R; Liu H; Zhang P; Zhu HH
Br J Haematol; 2024 Jun; 204(6):2301-2318. PubMed ID: 38685813
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia.
Waibel M; Vervoort SJ; Kong IY; Heinzel S; Ramsbottom KM; Martin BP; Hawkins ED; Johnstone RW
Leukemia; 2018 Jan; 32(1):237-241. PubMed ID: 28914259
[No Abstract] [Full Text] [Related]
14. Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells.
Rao SS; O'Neil J; Liberator CD; Hardwick JS; Dai X; Zhang T; Tyminski E; Yuan J; Kohl NE; Richon VM; Van der Ploeg LH; Carroll PM; Draetta GF; Look AT; Strack PR; Winter CG
Cancer Res; 2009 Apr; 69(7):3060-8. PubMed ID: 19318552
[TBL] [Abstract][Full Text] [Related]
15. T cell acute lymphoblastic leukemia: NOTCHing the way toward a better treatment outcome.
Pui CH
Cancer Cell; 2009 Feb; 15(2):85-7. PubMed ID: 19185842
[TBL] [Abstract][Full Text] [Related]
16. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols.
Zuurbier L; Homminga I; Calvert V; te Winkel ML; Buijs-Gladdines JG; Kooi C; Smits WK; Sonneveld E; Veerman AJ; Kamps WA; Horstmann M; Petricoin EF; Pieters R; Meijerink JP
Leukemia; 2010 Dec; 24(12):2014-22. PubMed ID: 20861909
[TBL] [Abstract][Full Text] [Related]
17. The frequency of NOTCH1 variants in T-acute lymphoblastic leukemia/lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma among Jordanian patients.
Abualhaj NZ; Dardas Z; Azab B; Ali D; Sughayer MA; Aladily TN; Ahram M
Ann Diagn Pathol; 2019 Apr; 39():53-58. PubMed ID: 30718223
[TBL] [Abstract][Full Text] [Related]
18. Targeting NOTCH1 in T-ALL: Starving the dragon.
Herranz D; Ferrando AA
Cell Cycle; 2016; 15(4):483-4. PubMed ID: 26864725
[No Abstract] [Full Text] [Related]
19. Therapeutic potential of Notch inhibition in T-cell acute lymphoblastic leukemia: rationale, caveats and promises.
Sarmento LM; Barata JT
Expert Rev Anticancer Ther; 2011 Sep; 11(9):1403-15. PubMed ID: 21929314
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of identical NOTCH1 mutation in non-twinned sisters with T-cell acute lymphoblastic leukemia.
Mansur MB; Ford AM; van Delft FW; Gonzalez D; Emerenciano M; Maia RC; Greaves M; Pombo-de-Oliveira MS
Leukemia; 2011 Aug; 25(8):1368-70. PubMed ID: 21556011
[No Abstract] [Full Text] [Related]
[Next] [New Search]
